Clinical instrumental serological and histological findings suggest that

  • Slides: 7
Download presentation
Clinical, instrumental, serological and histological findings suggest that hemophilia B may be less severe

Clinical, instrumental, serological and histological findings suggest that hemophilia B may be less severe than hemophilia A by Daniela Melchiorre, Silvia Linari, Mirko Manetti, Eloisa Romano, Francesco Sofi, Marco Matucci-Cerinic, Christian Carulli, Massimo Innocenti, Lidia Ibba-Manneschi, and Giancarlo Castaman haematol Volume 101(2): 219 -225 February 1, 2016 © 2016 by Ferrata Storti Foundation

Clinical characteristics of hemophilia A and hemophilia B patient groups. Daniela Melchiorre et al.

Clinical characteristics of hemophilia A and hemophilia B patient groups. Daniela Melchiorre et al. Haematologica 2016; 101: 219 -225 © 2016 by Ferrata Storti Foundation

Clinical and imaging findings of hemophilia A and hemophilia B patient groups. Daniela Melchiorre

Clinical and imaging findings of hemophilia A and hemophilia B patient groups. Daniela Melchiorre et al. Haematologica 2016; 101: 219 -225 © 2016 by Ferrata Storti Foundation

US findings of hemophilia A and hemophilia B patient groups. Daniela Melchiorre et al.

US findings of hemophilia A and hemophilia B patient groups. Daniela Melchiorre et al. Haematologica 2016; 101: 219 -225 © 2016 by Ferrata Storti Foundation

Clinical, serological and imaging findings of hemophilia A and hemophilia B patient groups according

Clinical, serological and imaging findings of hemophilia A and hemophilia B patient groups according to the number of hemarthrosis. Daniela Melchiorre et al. Haematologica 2016; 101: 219 -225 © 2016 by Ferrata Storti Foundation

Circulating levels of osteoprotegerin (OPG) and soluble receptor activator of nuclear factor-κB ligand (s.

Circulating levels of osteoprotegerin (OPG) and soluble receptor activator of nuclear factor-κB ligand (s. RANKL). Daniela Melchiorre et al. Haematologica 2016; 101: 219 -225 © 2016 by Ferrata Storti Foundation

Expression of receptor activator of nuclear factor-κB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG)

Expression of receptor activator of nuclear factor-κB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in synovial tissue from patients with hemophilia A, hemophilia B and osteoarthritis. Daniela Melchiorre et al. Haematologica 2016; 101: 219 -225 © 2016 by Ferrata Storti Foundation